Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

[1]  J. Holton,et al.  PINK1 protein in normal human brain and Parkinson's disease. , 2006, Brain : a journal of neurology.

[2]  T. C. Dickson,et al.  Alpha-synuclein is upregulated in neurones in response to chronic oxidative stress and is associated with neuroprotection , 2006, Experimental Neurology.

[3]  M. Graeber,et al.  Comparative study of commercially available anti‐α‐synuclein antibodies , 2006, Neuropathology and applied neurobiology.

[4]  L. Moran,et al.  Correction: Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition , 2006, Journal of Neuroinflammation.

[5]  W. Streit,et al.  Microglia in the Aging Brain , 2006, Journal of neuropathology and experimental neurology.

[6]  Alexander Hammers,et al.  In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease , 2006, Neurobiology of Disease.

[7]  A. Volterra,et al.  Defective Tumor Necrosis Factor-α-dependent Control of Astrocyte Glutamate Release in a Transgenic Mouse Model of Alzheimer Disease* , 2005, Journal of Biological Chemistry.

[8]  R. Reynolds,et al.  NG2‐expressing cells as oligodendrocyte progenitors in the normal and demyelinated adult central nervous system , 2005, Journal of anatomy.

[9]  W. Langston,et al.  α-Synuclein expression in the substantia nigra of MPTP-lesioned non-human primates , 2005, Neurobiology of Disease.

[10]  W. Poewe,et al.  Animal models of multiple system atrophy , 2005, Trends in Neurosciences.

[11]  P. Moynagh.  The interleukin‐1 signalling pathway in astrocytes: a key contributor to inflammation in the brain , 2005, Journal of anatomy.

[12]  Lingxin Kong,et al.  Comparison of the capability of GDNF, BDNF, or both, to protect nigrostriatal neurons in a rat model of Parkinson's disease , 2005, Brain Research.

[13]  W. Poewe,et al.  In vitro models of multiple system atrophy , 2005, Movement disorders : official journal of the Movement Disorder Society.

[14]  P. Jenner,et al.  The acute and the long‐term effects of nigral lipopolysaccharide administration on dopaminergic dysfunction and glial cell activation , 2005, The European journal of neuroscience.

[15]  Katsuhito Yasuno,et al.  Glutathione‐S‐transferase‐1 and interleukin‐1β gene polymorphisms in Japanese patients with Parkinson's disease , 2005 .

[16]  W. Gan,et al.  ATP mediates rapid microglial response to local brain injury in vivo , 2005, Nature Neuroscience.

[17]  T. Möller,et al.  Astrocyte-Derived ATP Induces Vesicle Shedding and IL-1β Release from Microglia1 , 2005, The Journal of Immunology.

[18]  F. Helmchen,et al.  Resting Microglial Cells Are Highly Dynamic Surveillants of Brain Parenchyma in Vivo , 2005, Science.

[19]  E. Eriksson,et al.  Investigation of genes coding for inflammatory components in Parkinson's disease , 2005, Movement disorders : official journal of the Movement Disorder Society.

[20]  J. Trojanowski,et al.  Mouse Model of Multiple System Atrophy α-Synuclein Expression in Oligodendrocytes Causes Glial and Neuronal Degeneration , 2005, Neuron.

[21]  T. Robbins,et al.  The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson’s disease , 2005, Journal of Neurology.

[22]  B. Banwell,et al.  Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease , 2005, Annals of neurology.

[23]  Werner Poewe,et al.  Oxidative stress in transgenic mice with oligodendroglial alpha-synuclein overexpression replicates the characteristic neuropathology of multiple system atrophy. , 2005, The American journal of pathology.

[24]  R. Kaji,et al.  Influence of a tumor necrosis factor gene polymorphism in Japanese patients with multiple system atrophy , 2005, Neuroscience Letters.

[25]  E. Eriksson,et al.  Interaction of polymorphisms in the genes encoding interleukin‐6 and estrogen receptor beta on the susceptibility to Parkinson's disease , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[26]  E. Yoshikawa,et al.  Microglial activation and dopamine terminal loss in early Parkinson's disease , 2005, Annals of neurology.

[27]  Mari Yoshida,et al.  Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains , 2005, Acta Neuropathologica.

[28]  Fumiaki Tanaka,et al.  Tuft-shaped astrocytes in Lewy body disease , 2005, Acta Neuropathologica.

[29]  O. Combarros,et al.  Interleukin-8, intercellular adhesion molecule-1 and tumour necrosis factor-α gene polymorphisms and the risk for multiple system atrophy , 2005, Journal of the Neurological Sciences.

[30]  D. Dickson.  Required techniques and useful molecular markers in the neuropathologic diagnosis of neurodegenerative diseases , 2005, Acta Neuropathologica.

[31]  T. Bártfai,et al.  Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment , 2004, Neuroscience.

[32]  A. Majid,et al.  The Potential of Minocycline for Neuroprotection in Human Neurologic Disease , 2004, Clinical neuropharmacology.

[33]  W. Poewe,et al.  Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration , 2004, Journal of neuroscience research.

[34]  Niall P Quinn,et al.  The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: clinicopathological correlations. , 2004, Brain : a journal of neurology.

[35]  E. Hirsch,et al.  Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1 year after MPTP exposure , 2004, Glia.

[36]  Eden R Martin,et al.  Fibroblast growth factor 20 polymorphisms and haplotypes strongly influence risk of Parkinson disease. , 2004, American journal of human genetics.

[37]  M. Ebadi,et al.  1‐Benzyl‐1,2,3,4‐tetrahydroisoquinoline, a Parkinsonism‐inducing endogenous toxin, increases α‐synuclein expression and causes nuclear damage in human dopaminergic cells , 2004, Journal of neuroscience research.

[38]  J. Feldon,et al.  Genetic ablation of tumor necrosis factor‐alpha (TNF‐α) and pharmacological inhibition of TNF‐synthesis attenuates MPTP toxicity in mouse striatum , 2004, Journal of neurochemistry.

[39]  Y. Itoyama,et al.  Histochemical features of stress-induced aggregates in α-synuclein overexpressing cells , 2004, Brain Research.

[40]  D. Middleton,et al.  Functional promoter region polymorphism of the proinflammatory chemokine IL-8 gene associates with Parkinson's disease in the Irish. , 2004, Human immunology.

[41]  G. Bartzokis.  Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[42]  H. Braak,et al.  Poor and protracted myelination as a contributory factor to neurodegenerative disorders , 2004, Neurobiology of Aging.

[43]  D. Sparks,et al.  Dystrophic microglia in the aging human brain , 2004, Glia.

[44]  Rossana Migheli,et al.  Glucocorticoid receptor deficiency increases vulnerability of the nigrostriatal dopaminergic system: critical role of glial nitric oxide , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  T. Mizutani,et al.  Microglial Activation Parallels System Degeneration in Multiple System Atrophy , 2004, Journal of neuropathology and experimental neurology.

[46]  S. Tsai,et al.  Brain-derived neurotrophic factor (BDNF) Val66Met polymorphisms in Parkinson's disease and age of onset , 2003, Neuroscience Letters.

[47]  S. Haber,et al.  Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys , 2003, Experimental Neurology.

[48]  Alan Peters,et al.  Disrupted myelin and axon loss in the anterior commissure of the aged rhesus monkey , 2003, The Journal of comparative neurology.

[49]  O. Combarros,et al.  Interleukin‐1A (−889) genetic polymorphism increases the risk of multiple system atrophy , 2003, Movement disorders : official journal of the Movement Disorder Society.

[50]  Andre Parent,et al.  Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administration , 2003, Annals of neurology.

[51]  S. Lorenzl,et al.  Minocycline enhances MPTP toxicity to dopaminergic neurons , 2003, Journal of neuroscience research.

[52]  Makoto Sawada,et al.  Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains , 2003, Acta Neuropathologica.

[53]  Hernan Cardenas,et al.  Compromised reactive microgliosis in MPTP-lesioned IL-6 KO mice , 2003, Brain Research.

[54]  R B Banati,et al.  [11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy , 2003, Neurology.

[55]  K. Jellinger,et al.  Neuropathological spectrum of synucleinopathies , 2003, Movement disorders : official journal of the Movement Disorder Society.

[56]  Y. Itoyama,et al.  Association between a polymorphism of brain‐derived neurotrophic factor gene and sporadic Parkinson's disease , 2003, Annals of neurology.

[57]  W. Willett,et al.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.

[58]  B. Pakkenberg,et al.  Marked loss of myelinated nerve fibers in the human brain with age , 2003, The Journal of comparative neurology.

[59]  T. Morgan,et al.  Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity , 2003, Experimental Neurology.

[60]  P. Mcgeer,et al.  Expression of complement messenger RNAs and proteins by human oligodendroglial cells , 2003, Glia.

[61]  E. Eriksson,et al.  Lack of association between the BDNF Val66Met polymorphism and Parkinson's disease in a Swedish population , 2003, Annals of neurology.

[62]  G. Sobue,et al.  α‐Synuclein‐positive structures in association with diffuse neurofibrillary tangles with calcification , 2003, Neuropathology and applied neurobiology.

[63]  T. Iwatsubo,et al.  Accumulation of Phosphorylated α‐Synuclein in Aging Human Brain , 2003 .

[64]  J. Kril,et al.  Severity of gliosis in Pick's disease and frontotemporal lobar degeneration: tau-positive glia differentiate these disorders. , 2003, Brain : a journal of neurology.

[65]  A. Kakita,et al.  α-Synuclein pathology affecting Bergmann glia of the cerebellum in patients with α-synucleinopathies , 2003, Acta Neuropathologica.

[66]  B. Volpe,et al.  Age-related microglial activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurodegeneration in C57BL/6 mice , 2003, Brain Research.

[67]  G. Donnan,et al.  Macrophages and Microglia Produce Local Trophic Gradients That Stimulate Axonal Sprouting Toward but Not beyond the Wound Edge , 2002, Molecular and Cellular Neuroscience.

[68]  Hitoshi Takahashi,et al.  Upregulation of α‐synuclein by lipopolysaccharide and interleukin‐1 in human macrophages , 2002 .

[69]  Hitoshi Takahashi,et al.  Demonstration of α-Synuclein Immunoreactivity in Neuronal and Glial Cytoplasm in Normal Human Brain Tissue Using Proteinase K and Formic Acid Pretreatment , 2002, Experimental Neurology.

[70]  R. Kaji,et al.  Contribution of the interleukin‐1β gene polymorphism in multiple system atrophy , 2002 .

[71]  R. Krüger,et al.  Polymorphisms in the interleukin-1 alpha and beta genes and the risk for Parkinson's disease , 2002, Neuroscience Letters.

[72]  T. Lehtimäki,et al.  Association of an interleukin 1B gene polymorphism (−511) with Parkinson's disease in Finnish patients , 2002, Journal of medical genetics.

[73]  Hideo Fujiwara,et al.  Hyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes , 2002 .

[74]  Dong-Kug Choi,et al.  Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease , 2002, The Journal of Neuroscience.

[75]  C. Duyckaerts,et al.  Alpha-synuclein-immunoreactive deposits in human and animal prion diseases , 2002, Acta Neuropathologica.

[76]  Alan Peters,et al.  Aging and the myelinated fibers in prefrontal cortex and corpus callosum of the monkey , 2002, The Journal of comparative neurology.

[77]  Ichiro Kanazawa,et al.  Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms , 2002, Annals of neurology.

[78]  M. Graeber,et al.  Transformation of donor‐derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy , 2001, Journal of neuroscience research.

[79]  寺田 整司.  Tau-negative astrocytic star-like inclusions and coiled bodies in dementia with Lewy bodies , 2001 .

[80]  R. Kaji,et al.  Tumor necrosis factor gene polymorphisms in patients with sporadic Parkinson's disease , 2001, Neuroscience Letters.

[81]  W. Le,et al.  Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum , 2001, Brain Research.

[82]  H. Soininen,et al.  α‐Synuclein pathology is highly dependent on the case selection , 2001, Neuropathology and applied neurobiology.

[83]  K. Wakabayashi,et al.  Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta. , 2001, Neuroreport.

[84]  W. Oertel,et al.  A polymorphism in the intronic region of the IL-1α gene and the risk for Parkinson’s disease , 2001, Neurology.

[85]  K. Dietz,et al.  Local distribution of microglia in the normal adult human central nervous system differs by up to one order of magnitude , 2001, Acta Neuropathologica.

[86]  H. Akiyama,et al.  Glial involvement in the degeneration process of Lewy body-bearing neurons and the degradation process of Lewy bodies in brains of dementia with Lewy bodies , 2001, Journal of the Neurological Sciences.

[87]  T. Beach,et al.  Distinct isoforms of tau aggregated in neurons and glial cells in brains of patients with Pick's disease, corticobasal degeneration and progressive supranuclear palsy , 2001, Acta Neuropathologica.

[88]  C. Masters,et al.  The solubility of α‐synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease , 2001 .

[89]  P. Eikelenboom,et al.  Activated microglial cells and complement factors are unrelated to cortical Lewy bodies , 2000, Acta Neuropathologica.

[90]  J. Trojanowski,et al.  α‐synuclein is developmentally expressed in cultured rat brain oligodendrocytes , 2000, Journal of neuroscience research.

[91]  T. Montine,et al.  Immunohistochemical and Biochemical Studies Demonstrate a Distinct Profile of α‐Synuclein Permutations in Multiple System Atrophy , 2000, Journal of neuropathology and experimental neurology.

[92]  J. Trojanowski,et al.  Neurodegeneration with Brain Iron Accumulation, Type 1 Is Characterized by α-, β-, and γ-Synuclein Neuropathology , 2000 .

[93]  R. Hamilton,et al.  Lewy Bodies in Alzheimer's Disease: A Neuropathological Review of 145 Cases Using α‐Synuclein Immunohistochemistry , 2000, Brain pathology.

[94]  Y. Piao,et al.  Aggregation of alpha-synuclein/NACP in the neuronal and glial cells in diffuse Lewy body disease: a survey of six patients. , 2000, Clinical neuropathology.

[95]  T. Iwatsubo,et al.  α‐Synuclein Inclusions in Amygdala in the Brains of Patients with the Parkinsonism‐Dementia Complex of Guam , 2000, Journal of neuropathology and experimental neurology.

[96]  Masako Kato,et al.  Midkine, a new neurotrophic factor, is present in glial cytoplasmic inclusions of multiple system atrophy brains , 2000, Acta Neuropathologica.

[97]  C. Plata-salamán,et al.  Inflammation and Alzheimer’s disease , 2000, Neurobiology of Aging.

[98]  I. Mizuta,et al.  Influence of interleukin-1β gene polymorphisms on age-at-onset of sporadic Parkinson's disease , 2000, Neuroscience Letters.

[99]  E. Masliah,et al.  C-terminal α-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders , 2000, Acta Neuropathologica.

[100]  S. Hayashi,et al.  NACP/α-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson’s disease brains , 2000, Acta Neuropathologica.

[101]  D. Munoz.  Stains for the differential diagnosis of degenerative dementias. , 1999, Biotechnic & histochemistry : official publication of the Biological Stain Commission.

[102]  T. Komori,et al.  Tau‐positive dial Inclusions in Progressive Supranuclear Palsy, Corticobasal Degeneration and Pick's Disease , 1999, Brain pathology.

[103]  D. Dickson,et al.  Multiple System Atrophy: A Sporadic Synucleinopathy , 1999, Brain pathology.

[104]  Sid Gilman,et al.  Widespread Alterations of α-Synuclein in Multiple System Atrophy , 1999 .

[105]  S Gilman,et al.  Widespread alterations of alpha-synuclein in multiple system atrophy. , 1999, The American journal of pathology.

[106]  W. Streit,et al.  Reactive microgliosis , 1999, Progress in Neurobiology.

[107]  M. Laakso,et al.  Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue , 1999, Acta Neuropathologica.

[108]  Geoffrey A. Donnan,et al.  Activated Macrophages and Microglia Induce Dopaminergic Sprouting in the Injured Striatum and Express Brain-Derived Neurotrophic Factor and Glial Cell Line-Derived Neurotrophic Factor , 1999, The Journal of Neuroscience.

[109]  K. Nakashima,et al.  A comparison of tau protein in cerebrospinal fluid between corticobasal degeneration and progressive supranuclear palsy , 1999, Neuroscience Letters.

[110]  J Q Trojanowski,et al.  Lewy bodies contain altered alpha-synuclein in brains of many familial Alzheimer's disease patients with mutations in presenilin and amyloid precursor protein genes. , 1998, The American journal of pathology.

[111]  M. Goedert,et al.  Lewy body diseases and multiple system atrophy as α-synucleinopathies , 1998, Molecular Psychiatry.

[112]  Shigeo Hirai,et al.  NACP/α-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy , 1998, Acta Neuropathologica.

[113]  P. Mcgeer,et al.  Myelin degeneration in multiple system atrophy detected by unique antibodies. , 1998, The American journal of pathology.

[114]  J Q Trojanowski,et al.  Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein , 1998, Annals of neurology.

[115]  Nigel J. Cairns,et al.  Filamentous α-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies , 1998, Neuroscience Letters.

[116]  Hitoshi Takahashi,et al.  α-Synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy , 1998, Neuroscience Letters.

[117]  N. Berman,et al.  Microglial Expression of MHC Class II Increases in Normal Aging of Nonhuman Primates , 1998, Neurobiology of Aging.

[118]  T. Morgan,et al.  Age-Related Activation of Microglia and Astrocytes: In Vitro Studies Show Persistent Phenotypes of Aging, Increased Proliferation, and Resistance to Down-Regulation , 1998, Neurobiology of Aging.

[119]  A. Ho,et al.  Regulation of Astroglial-Derived Dopaminergic Neurotrophic Factors by Interleukin-1β in the Striatum of Young and Middle-Aged Mice , 1997, Experimental Neurology.

[120]  K. Arima,et al.  Ultrastructural characterization of the tau-immunoreactive tubules in the oligodendroglial perikarya and their inner loop processes in progressive supranuclear palsy , 1997, Acta Neuropathologica.

[121]  A. van Dam,et al.  Inhibition of endotoxin‐induced nitric oxide synthase production in microglial cells by the presence of astroglial cells: A role for transforming growth factor β , 1997 .

[122]  N. Rothwell,et al.  Cytokines and acute neurodegeneration , 1997, Molecular Psychiatry.

[123]  M. Graeber,et al.  On the question of apoptosis in the parkinsonian substantia nigra , 1997, Acta Neuropathologica.

[124]  R B Banati,et al.  PK (‘peripheral benzodiazepine’) – binding sites in the CNS indicate early and discrete brain lesions: microautoradiographic detection of [3H]PK 11195 binding to activated microglia , 1997, Journal of neurocytology.

[125]  A. Członkowska,et al.  Microglial reaction in MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) induced Parkinson's disease mice model. , 1996, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.

[126]  D. Sparks,et al.  Activation of microglia in the brains of humans with heart disease and hypercholesterolemic rabbits , 1996, Journal of Molecular Medicine.

[127]  Y. Agid,et al.  Nitric oxide synthase and neuronal vulnerability in parkinson's disease , 1996, Neuroscience.

[128]  P. Mcgeer,et al.  Midkine-like immunoreactivity in extracellular neurofibrillary tangles in brains of patients with parkinsonism-dementia complex of Guam , 1996, Neuroscience Letters.

[129]  Junya Tanaka,et al.  Microglial Ramification Requires Nondiffusible Factors Derived from Astrocytes , 1996, Experimental Neurology.

[130]  Peter Riederer,et al.  Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.

[131]  M. Mattson,et al.  Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[132]  E. Benveniste,et al.  Class II MHC gene expression in microglia. Regulation by the cytokines IFN-gamma, TNF-alpha, and TGF-beta. , 1995, Journal of immunology.

[133]  P. Riederer,et al.  Interleukin-1β, interleukin-6, epidermal growth factor and transforming growth factor-α are elevated in the brain from parkinsonian patients , 1994, Neuroscience Letters.

[134]  M. Graeber,et al.  CR3/43, a marker for activated human microglia: application to diagnostic neuropathology , 1994, Neuropathology and applied neurobiology.

[135]  M. Yoshida,et al.  Effects of ageing on microglia in the normal rat brain: immunohistochemical observations. , 1994, Neuroreport.

[136]  E. Hirsch,et al.  Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease , 1994, Neuroscience Letters.

[137]  M. Mattson,et al.  Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis , 1994, Neuron.

[138]  Minoru Harada,et al.  Tumor necrosis factor-α (TNF-α) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients , 1994, Neuroscience Letters.

[139]  G. Moretto,et al.  Midkine that promotes survival of fetal human neurons is produced by fetal human astrocytes in culture. , 1993, Brain research. Developmental brain research.

[140]  E. Unger,et al.  Male Donor‐derived Cells in the Brains of Female Sex‐mismatched Bone Marrow Transplant Recipients: A Y‐Chromosome Specific In situ Hybridization Study , 1993, Journal of neuropathology and experimental neurology.

[141]  M. Cuzner,et al.  Modulation of interferon-gamma-induced major histocompatibility complex class II and Fc receptor expression on isolated microglia by transforming growth factor-beta 1, interleukin-4, noradrenaline and glucocorticoids. , 1993, Immunology.

[142]  Seung-Up Kim,et al.  Midkine, a novel neurotrophic factor, is present in senile plaques of Alzheimer disease. , 1993, Biochemical and biophysical research communications.

[143]  V. Perry,et al.  Altered antigen expression of microglia in the aged rodent CNS , 1993, Glia.

[144]  T. Molitor,et al.  Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. , 1992, Journal of immunology.

[145]  M. Simmons,et al.  Induction of Nitric Oxide Synthase in Glial Cells , 1992, Journal of neurochemistry.

[146]  P. Lantos,et al.  Accumulation of tubular structures in oligodendroglial and neuronal cells as the basic alteration in multiple system atrophy , 1992, Journal of the Neurological Sciences.

[147]  P. Lantos.  From slow virus to prion: a review of transmissible spongiform encephalopathies , 1992, Histopathology.

[148]  H. Hatanaka,et al.  Interleukin-6 improves the survival of mesencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures , 1991, Neuroscience.

[149]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[150]  K. Jellinger,et al.  Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.

[151]  D. Irving,et al.  Lewy body prevalence in the aging brain: relationship to neuropsychiatric disorders, Alzheimer-type pathology and catecholaminergic nuclei , 1990, Journal of the Neurological Sciences.

[152]  D. Dickson,et al.  Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors. , 1990, The American journal of pathology.

[153]  Peter L. Lantos,et al.  Glial cytoplasmic inclusions in the CNS of patients with multiple system atrophy (striatonigral degeneration, olivopontocerebellar atrophy and Shy-Drager syndrome) , 1989, Journal of the Neurological Sciences.

[154]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[155]  L. Forno,et al.  CONCENTRIC HYALIN INTRANEURONAL INCLUSIONS OF LEWY TYPE IN THE BRAINS OF ELDERLY PERSONS (50 INCIDENTAL CASES): RELATIONSHIP TO PARKINSONISM , 1969, Journal of the American Geriatrics Society.

[156]  T. Möller,et al.  Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. , 2005, Journal of immunology.

[157]  D. D. Di Monte,et al.  Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates. , 2005, Neurobiology of disease.

[158]  Katsuhito Yasuno,et al.  Glutathione-S-transferase-1 and interleukin-1beta gene polymorphisms in Japanese patients with Parkinson's disease. , 2005, Movement disorders : official journal of the Movement Disorder Society.

[159]  H. Ito,et al.  Argyrophilic ubiquitinated cytoplasmic inclusions of Leu-7-positive glial cells in olivopontocerebellar atrophy (multiple system atrophy) , 2004, Acta Neuropathologica.

[160]  P. Mcgeer,et al.  Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins , 2004, Acta Neuropathologica.

[161]  P. Mcgeer,et al.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease , 2004, Acta Neuropathologica.

[162]  J. Trojanowski,et al.  Expression of the small heat-shock protein alphaB-crystallin in tauopathies with glial pathology. , 2004, The American journal of pathology.

[163]  L. Rorke,et al.  Histopathology and electron microscopy of three cases of subacute sclerosing panencephalitis (SSPE) , 2004, Acta Neuropathologica.

[164]  Y. Itoyama,et al.  Histochemical features of stress-induced aggregates in alpha-synuclein overexpressing cells. , 2004, Brain research.

[165]  Hideo Fujiwara,et al.  Accumulation of phosphorylated alpha-synuclein in aging human brain. , 2003, Journal of neuropathology and experimental neurology.

[166]  A. Kakita,et al.  Alpha-synuclein pathology affecting Bergmann glia of the cerebellum in patients with alpha-synucleinopathies. , 2003, Acta neuropathologica.

[167]  M. Sasaki,et al.  Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. , 2002, Pathology international.

[168]  R. Kaji,et al.  Contribution of the interleukin-1beta gene polymorphism in multiple system atrophy. , 2002, Movement disorders : official journal of the Movement Disorder Society.

[169]  W. Spooren,et al.  Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes. , 2002, EMBO reports.

[170]  M. Graeber,et al.  Cellular pathology of the central nervous system. , 2002 .

[171]  P. Lantos,et al.  Greenfield's Neuropathology , 2002 .

[172]  菱川 望.  Widespread occurrence of argyrophilic glial inclusions in Parkinson's disease , 2001 .

[173]  I. Ferrer,et al.  Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies , 2001, Journal of Neural Transmission.

[174]  C. Masters,et al.  The solubility of alpha-synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease. , 2001, Journal of neurochemistry.

[175]  I. Mizuta,et al.  Influence of interleukin-1beta gene polymorphisms on age-at-onset of sporadic Parkinson's disease. , 2000, Neuroscience letters.

[176]  S. Hayashi,et al.  NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. , 2000, Acta neuropathologica.

[177]  Scott R. Barnum,et al.  INFLAMMATION AND ALZHEIMERS DISEASE , 2000 .

[178]  R A Crowther,et al.  Filamentous alpha-synuclein inclusions link multiple system atrophy with Parkinson's disease and dementia with Lewy bodies. , 1998, Neuroscience letters.

[179]  K. Arima,et al.  NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy. , 1998, Acta neuropathologica.

[180]  M. Goedert,et al.  Lewy body diseases and multiple system atrophy as alpha-synucleinopathies. , 1998, Molecular psychiatry.

[181]  S. Tsuji,et al.  Alpha-synuclein immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy. , 1998, Neuroscience letters.

[182]  Mrc Psych,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop , 1996 .

[183]  P Riederer,et al.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients. , 1995, Neuroscience letters.

[184]  P. Riederer,et al.  Interleukin-1 beta, interleukin-6, epidermal growth factor and transforming growth factor-alpha are elevated in the brain from parkinsonian patients. , 1994, Neuroscience letters.

[185]  P. Riederer,et al.  Tumor necrosis factor-alpha (TNF-alpha) increases both in the brain and in the cerebrospinal fluid from parkinsonian patients. , 1994, Neuroscience letters.

[186]  P. Mcgeer,et al.  Relationship of Complement-Activated Oligodendrocytes to Reactive Microglia and Neuronal Pathology in Neurodegenerative Disease , 1991 .